BIOTECH

作品数:67被引量:11H指数:2
导出分析报告
相关作者:王世春李星奇薛晓伟王德田邱广斌更多>>
相关机构:江苏省生产力促进中心北京协和医院台湾清华大学黄石市输血研究所更多>>
相关期刊:更多>>
相关基金:国家自然科学基金国家重点基础研究发展计划更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
医美龙头爱美客高溢价收购韩企
《品质》2025年第4期7-7,共1页
3月10日,中国医美龙头爱美客宣布通过控股子公司以1.9亿美元收购韩国REGEN Biotech公司85%股权,交易完成后将间接持有该公司59.5%股份并纳入合并报表。值得关注的是,这并非本次并购的全部,据悉,剩余股权还将在首期交割18个月后灵活收购...
关键词:REGEN Biotech 爱美客 韩企 医美 溢价 
Three decades and beyond:Breeding,biotech breakthroughs and future of China's GM insect-resistant cotton
《Journal of Integrative Agriculture》2024年第10期3243-3249,共7页Chengzhen Liang Shuangxia Jin 
Cotton(Gossypium spp.)is a pivotal crop in the global textile industry,providing essential natural fibers.Additionally,cottonseed offers significant value as a source of oil and as feed for livestock(Huang et al.2021;...
关键词:BREAKTHROUGH COTTON finished 
Fast-to-Clinic, Fast-to-Market in Biotech Innovation: Optimizing Chemistry Manufacturing & Controls (CMC) Excellence for Clinical and Commercial Success
《Advances in Chemical Engineering and Science》2024年第3期155-171,共17页Kishore Kumar Hotha 
In the emerging world of biotech innovation, the fast-to-clinic/market strategy has emerged as a critical “mantra” for biotech, investors, and CDMOs. This approach addresses the escalating costs and complexities of ...
关键词:Fast to Clinic INNOVATION CDMO CMC PRECLINICAL FDA IND NDA ANDA BIOTECH 
Evaluation of a Rapid Diagnostic Test, Boson Biotech SARS CoV-2 Ag, for the Detection of SARS-CoV-2 in Gabon
《Advances in Infectious Diseases》2024年第2期469-477,共9页Samira Zoa Assoumou Ulrich Leger Davy Mouangala Ludovic Mewono Davy-Christ Angoune Ndong Guy Paterne Malonga Mbembo Nely Meungang Alain Moutsinga Elvyre Anita Mbongo Kama Rodrigue Mintsa Nguema 
1) Background: Rapid and acurate diagnostic testing for case identification, quarantine, and contact tracing is essential for managing the COVID 19 pandemic. Rapid antigen detection tests are available, however, it is...
关键词:SARS-CoV-2 Rapid Diagnostic Test EVALUATION COVID-19 ANTIGEN Performance 
Osteotomy Protocol for Implant Insertion of One Day Biotech: One Drill, One Implant
《Open Journal of Stomatology》2024年第5期255-277,共23页Jin Hwan Kim Jaehyun Song Jaegyun Choi Jose Francisco Ballester Ireh Kim Santiago Jose Ballester 
Background: Four factors determine the quality of an implantology kit: 1) Heat generated by the drills;2) Morphology of the osteotomy according to the diameter of the implant;3) Efficiency of collecting autologous bon...
关键词:Dental Implant Bur Primary Stability Drilling Time OSTEOTOMY Irrigation Bone Collected 
Yi Larson:Biotech CFO,Mentor&Soonto-Be Mother of 4
《城市漫步(上海版、英文)》2023年第6期30-31,共2页Ned Kelly 
Born in sweltering Guangzhou,Yi Larson emigrated to snowy Buffalo,New York with her family when she was just five years old.After an illustrious career in finance in the US–including 10 years working at Goldman Sachs...
关键词:FINANCE investment RETURN 
Yi Larson:Biotech CFO,Mentor&Soon-to-Be Mother of 4
《城市漫步(GBA版)》2023年第6期30-31,共2页Ned Kelly 
Born in sweltering Guangzhou,Yi Larson emigrated to snowy Buffalo,New York with her family when she was just five years old.Afteran llustrious careerin finance in the US-including 10 years working at Goldman Sachs,the...
关键词:FINANCE investment RETURN 
Genome editing and human rights:Implications of the UNGPs
《Biosafety and Health》2022年第6期386-391,共6页Leifan Wang Xiaohui Liang Weiwen Zhang 
supported by grants from the National Key Research and Development Program of China(Grant nos.2019YFA0904600 and 2020YFA0908600).
How to address the impact of genome editing on human rights is a global challenge.The World Health Organization(WHO)recently developed a governance framework for human genome editing to provide global recommendations ...
关键词:Genome editing Human rights UNGPs Biotech enterprises 
Biotech公司竞争战略与创新发展对策被引量:1
《药物生物技术》2022年第5期441-447,共7页王世春 程娟 赵忠卫 
江苏省政策引导类计划(软科学研究)(No.BR2021035)。
在政策鼓励和市场需求下,外加技术和资本的助推,国内各种类型的Biotech公司已超过1000家,获批进入临床研究的新分子创新药也已经超过1000个,国内的Biotech公司进入高速爆发和增长期。为了研究Biotech公司竞争战略与创新发展对策,文章比...
关键词:BIOTECH 波特模型 医药企业 发展战略 科技创新 快速响应 创新对策 
Biotech key to unlock mineral resources value被引量:4
《Transactions of Nonferrous Metals Society of China》2022年第7期2309-2317,共9页Guan-zhou QIU Xue-duan LIU 
financial support from the High-Tech Demonstration Program of the National Development and Reform Commission (2001,No.1907);the National Basic Research Program of China (Nos.2004CB619200,2010CB630900);the National High-tech Research and Development Program of China (Nos.2007AA060900,2012AA061500);the National Natural Science Foundation of China (Nos.50321402,50621063);the “111” Project of the Ministry of Education of China (No.B07043)。
This work aims to describe the history of biometallurgy in China,introduce the development and application of biometallurgy technologies in exploitation of mineral resources,and identify the main challenges and future...
关键词:BIOTECHNOLOGY biometallurgy BIOLEACHING mineral resources nonferrous metals 
检索报告 对象比较 聚类工具 使用帮助 返回顶部